1. Home
  2. AUST vs BNGO Comparison

AUST vs BNGO Comparison

Compare AUST & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Austin Gold Corp.

AUST

Austin Gold Corp.

SELL

Current Price

$0.53

Market Cap

13.3M

Sector

N/A

ML Signal

SELL

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$0.84

Market Cap

14.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUST
BNGO
Founded
2020
2003
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
13.3M
14.5M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
AUST
BNGO
Price
$0.53
$0.84
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.8K
★ 239.7K
Earning Date
11-05-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 94.50
EPS
★ N/A
N/A
Revenue
N/A
★ $12,000,735.00
Revenue This Year
N/A
$13.91
Revenue Next Year
N/A
$33.34
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 26.26
52 Week Low
$0.58
$0.87
52 Week High
$3.92
$2.23

Technical Indicators

Market Signals
Indicator
AUST
BNGO
Relative Strength Index (RSI) 24.58 29.73
Support Level N/A N/A
Resistance Level $1.43 $1.35
Average True Range (ATR) 0.08 0.09
MACD -0.01 -0.02
Stochastic Oscillator 0.00 3.44

Price Performance

Historical Comparison
AUST
BNGO

About AUST Austin Gold Corp.

Austin Gold Corp is focused on the acquisition, exploration, and evaluation of mineral resource properties in the western United States of America (USA). The exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek, Lone Mountain, Stockade Mountain, Fourmile Basin, and Miller.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Share on Social Networks: